2026-01-24 - Analysis Report
**Company Overview:**
Intuitive Surgical is a medical technology company that designs, manufactures, and markets robotic-assisted surgical systems.

**Return Rate Comparison:**

* Cumulative Return (ISRG): **200.14%**
* Cumulative Return (VOO): **126.41%**
* Divergence: **73.70** (relative divergence: **47.10%**)

The cumulative return of ISRG is significantly higher than that of VOO, indicating a greater growth in value.

**Alpha, Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|-----|-------|------|--------|
| 2016-2018 | 68.0% | 22.1% | 56.0% | 1.2 | 57.2B |
| 2017-2019 | 72.0% | 22.1% | 47.0% | 1.4 | 70.6B |
| 2018-2020 | 54.0% | 39.8% | 30.0% | 1.2 | 97.8B |
| 2019-2021 | 93.0% | 39.8% | 27.0% | 1.2 | 128.8B |
| 2020-2022 | 17.0% | 46.2% | 10.0% | 1.2 | 95.1B |
| 2021-2023 | 16.0% | 46.2% | -4.0% | 1.4 | 120.9B |
| 2022-2024 | 108.0% | 37.1% | 78.0% | 1.3 | 187.1B |
| 2023-2025 | 152.0% | 27.8% | 77.0% | 1.2 | 203.0B |

The Alpha, Beta analysis shows a generally positive trend, with the highest CAGR (68.0%) in the 2016-2018 period and the highest Beta (1.4) in the 2017-2019 period.

**Recent Stock Price Fluctuations:**

* Close: **$523.99**
* Last-market: **$523.99** (change: -0.35%)
* 5-day SMA: **$527.19**
* 20-day SMA: **$560.64**
* 60-day SMA: **$559.74**

**Market Risk Indicator (MRI)**: **0.70** (medium investment)

**RSI, PPO Index Indicators:**

* RSI: **32.13**
* PPO: **-1.15**

The RSI indicator shows a bearish trend, while the PPO indicator suggests a bearish trend. The Hybrid Signal is currently "Buy" with 0% cash.

**Recent (20 days) relative divergence change**: **-5.00**
**7-day Rank change**: **75**
**7-day Dynamic Expected Return change**: **67.40**

The fluctuation issue is a sharp rebound.

**Expected Return (%):** **75.40%**

**Recent News & Significant Events:**

* Why This Robotics Giant's Lackluster Guidance Isn't All Doom - Investor's Business Daily
* Biggest stock movers Friday: INTC, ISRG, FTNT, and more - Seeking Alpha
* ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines - Zacks Investment Research
* ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now? - Yahoo Finance
* Where Will Intuitive Surgical Be in 5 Years? - The Motley Fool
* 2 Healthcare Names That Could Get a Big Boost From Earnings - MarketBeat

**Analyst Opinions:**

* Analyst Consensus:
 - Key: Buy
 - Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
 - Opinions: 29
 - Target Price (avg/high/low): 607.19 / 750.00 / 378.00

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-22 | 1.98 | $2.51B |
| 2025-07-23 | 1.84 | $2.44B |
| 2025-04-23 | 1.95 | $2.25B |
| 2024-10-18 | 1.59 | $2.04B |
| 2025-10-22 | 1.59 | $2.04B |

The recent earnings analysis shows generally stable EPS and revenue growth, with a slight decline in the last quarter.

**Financial Information - Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |

**Financial Information - Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |

The financial information shows stable revenue and equity growth, with a slight decline in profit margin in the last quarter.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.